Repository logo
 
Publication

Anemia and Iron Deficiency Diagnosis, Management and Treatment in Chronic Kidney Disease - Consensus and Agreement through a Delphi Panel

2020Journal article Open access
Simple item page
dc.contributor.authorFerreira, A
dc.contributor.authorFarinha, A
dc.contributor.authorMacedo, A
dc.contributor.authorRobalo Nunes, A
dc.contributor.authorLopes, J
dc.contributor.authorBranco, P
dc.contributor.authorPonce, P
dc.contributor.authorNeto, R
dc.date.accessioned2021-04-15T15:35:50Z
dc.date.available2021-04-15T15:35:50Z
dc.date.issued2020
dc.description.abstractBackground: Anemia is a common complication of Chronic Kidney Disease (CKD), in which iron deficiency’s (ID) role is frequently underrated. In CKD, anemia has been associated with higher morbidity and lower quality of life. Nonetheless, reported treatment rates of anemia in CKD are low and guidelines’ variability and/or absence for its management and treatment may be preventing patients from receiving optimal treatment. Within this context, we aimed to assess the agreement level on anemia and iron deficiency diagnosis, management, and treatment in CKD patients, by Portuguese physicians in Nephrology, through a Delphi Panel. Methods: A group of seven medical experts in Nephrology and Transfusion Medicine was assembled, and a focus group was conducted, in which 28 statements were agreed upon. Then, a two-round Delphi Panel using a Likert scale was conducted online, inviting Portuguese Society of Nephrology associates to participate. Results: Answers were collected from 76 participants in Round 1 and consensus level was obtained for 1 statement, 57 (75%) respondents fully disagreeing on transfusing all patients with hemoglobin below 9 g/dl, regardless of the clinical situation. The remaining 27 statements were used in Round 2, none obtaining consensus level and 14 statements being categorized as qualified majority: 4 on diagnosis, 3 on disease management, and 7 on treatment. Discussion: Our study showed a lack of consensus on diagnosis, management, and treatment of anemia in CKD patients among the nephrology community in Portugal. Overall, our results illustrated the heterogeneity of national clinical practices in: laboratory parameters’ choice; cutoff values defining anemia and/or ID; parameter-based therapeutic decisions. Nonetheless, it was shown clear that patient’s individual characteristics, clinical settings, and the physician’s “clinical sense” seem to be considered to a further extent than the available guidelines. Future studies should be considered to develop recommendations that can be widely accepted.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationPort J Nephrol Hypert 2020;34(2):79-83pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/3662
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSociedade Portuguesa de Nefrologiapt_PT
dc.subjectHCC NEFpt_PT
dc.subjectAnemiapt_PT
dc.subjectChronic Kidney Diseasespt_PT
dc.subjectConsensuspt_PT
dc.subjectDelphi Techniquept_PT
dc.subjectIron-Deficiencypt_PT
dc.titleAnemia and Iron Deficiency Diagnosis, Management and Treatment in Chronic Kidney Disease - Consensus and Agreement through a Delphi Panelpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage83pt_PT
oaire.citation.startPage79pt_PT
oaire.citation.titleRevista Portuguesa de Nefrologia e Hipertensãopt_PT
oaire.citation.volume34pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Port J Nephrol 2020 79.pdf
Size:
300.51 KB
Format:
Adobe Portable Document Format
Download

Collections

NEF - Artigos